Dapagliflozin and empagliflozin cut mortality in patients with heart failure with reduced ejection fraction whether or not patients have diabetes, a large real-world study has concluded. The analysis ...

Diabetes and heart health are closely connected. People with diabetes have a higher risk of heart failure, a condition where ...

A study found that SGLT2 inhibitors, a hypoglycemic agent, are effective in 'hypertensive cardiomyopathy', a disease in which ...

INR:4968. entusiasta de blackjack "Pharmaceutical Quick Reading" AstraZeneca's dapagliflozin heart failure indication approved in China Changchun High-Tec ...

USA: Recent findings published in Arthritis Care and Research suggest that individuals with rheumatoid arthritis (RA) face an ...

DEAR DR. ROACH: I have a good friend who is almost 77 years old. He was a heavy smoker until about 14 years ago. He decided ...

(Balcinrenone + dapagliflozin) is under clinical development by AstraZeneca and currently in Phase II for Proteinuria.